Newsfeeds - Spark Newswire

4 minute read

The Week Ahead In Biotech (Sept. 12-18): Calliditas FDA Decision, Adcom Review For Pfizer/BioNTech COVID-19 Vaccine, Oncology Conference And IPOs

By Shanthi Rexaline

Today, 7:46 PM

Biotech stocks retreated in the holiday-shortened week ending Sept. 10, reversing course from the previous week.

ALRN

1 minute read

EMA Gives Nod To Additional Sites For Pfizer – BioNTech COVID-19 Vaccine

By Vandana Singh

Today, 7:46 PM

European Medical Agency (EMA) has approved additional manufacturing sites to produce Comirnaty, the COVID-19 vaccine developed by Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX).…

BNTX

1 minute read

Sanofi’s BTK Inhibitor Disappoints In Phase 3 Autoimmune Disease Trial

By Vandana Singh

Today, 7:46 PM

Sanofi SA's (NASDAQ: SNY) BTK inhibitor, rilzabrutinib, has flunked its first major clinical test. Rilzabrutinib was Principia Biopharma Inc's one of the key candidates that Sanofi acquired last year for $3.68 billion.

SNY

6 minute read

The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi’s Pemphigus Trial Disappointment, Humanigen’s COVID-19 Drug Denied Emergency Use Authorization

By Shanthi Rexaline

Today, 7:46 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8)

ABSI

2 minute read

Sanofi’s $1.9 Billion Bet On Kadmon: What You Need to Know

By Shanthi Rexaline

Today, 7:46 PM

Underlining the focus on inorganic growth, French pharma giant Sanofi (NASDAQ: SNY) announced a big-ticket acquisition just a month after another

KDMN

3 minute read

Sanofi to Acquire Kadmon for $9.50/Share in Cash

By Charles Gross

Today, 7:46 PM

Sanofi (NYSE: SNY) has entered into a definitive merger agreement with Kadmon Holdings, Inc. (NASDAQ: KDMN).

KDMN

5 minute read

Attention Biotech Investors: Mark Your Calendar For September PDUFA Dates

By Shanthi Rexaline

Today, 7:46 PM

August proved to be a mixed month for regulatory approvals, with the Food and Drug Administration approving a few, turning down a few others and delaying the remaining.

ABBV

1 minute read

Glaxo, SK Bioscience Start COVID-19 Vaccine Trial Against AstraZeneca Shot

By Vandana Singh

Today, 7:46 PM

GlaxoSmithKline Plc (NYSE:GSK) has started Phase 3 clinical study for a COVID-19 vaccine candidate designed by South Korean drugmaker SK Bioscience Co.…

AZN

1 minute read

Pfizer’s Abrocitinib Beats Dupixent Late-stage Eczema Trial

By Vandana Singh

Today, 7:46 PM

Pfizer Inc (NYSE:PFE) announced topline data from the JADE DARE Phase 3 trial comparing abrocitinib with Sanofi SA (NASDAQ:SNY) – Regeneron Pharmaceuticals Inc’s (NASDAQ:REGN) Dupixent…

PFE